Arrhythmogenic Right Ventricular Cardiomyopathy Treatment

Similar to other forms of cardiomyopathy, treatment for arrhythmogenic right ventricular cardiomyopathy (ARVC) is focused on heart failure and reducing the risk for sudden cardiac death.

The treatment goals are to:

  • Control symptoms of congestive heart failure
  • Prevent or control ventricular arrhythmias and sudden cardiac death

Common medications include:

  • Anti-arrhythmic medications such as amiodarone and disopyramide to reduce the risk of sudden cardiac death.

For more advanced disease, other interventions may be necessary such as:

  • Implantable pacemaker or defibrillator
  • Mechanical ventilator support (intubation)
  • Cardiac assist devices (ECMO, LVAD, BIVAD)
  • Heart transplantation

To learn more about these treatment options, read the sections on Medication, Implantable DevicesMechanical Cardiac Assist Devices, and Heart Transplantation.



Left Ventricular Non-Compaction Treatment


Stay Informed
Keep current on PCM research and CCF happenings in our Heart to Heart newsletter.
Unite and Fight
Connect with hundreds of other families struggling with this disease through our online member community.
Shop for a Cure
Shop for CCF merchandise to support our research and education efforts.
The Children's Cardiomyopathy Foundation is a 501 (c)(3) non-profit recognized by the U.S. Internal Revenue Service.
© 2020 Children's Cardiomyopathy Foundation. All rights reserved.